Edward Ludwig Insider Profile
4 Followers
Edward Ludwig, Director at Boston Scientific, holds 30.36K shares in Boston Scientific (Ticker: BSX), holds 32.71K shares in CVS Health (Ticker: CVS), holds 19.06K shares in Xylem (Ticker: XYL). Most recently, Edward Ludwig Bought ― shares of Boston Scientific on Aug 03, 2026 for an estimated value of $227.35K.
Profitable Transactions
10 out of 16 Profitable Transactions
Average Return
+9.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Edward Ludwig holds in companies
Most Profitable Insider Trade
The most profitable trade made by Edward Ludwig
Edward Ludwig's Trading History
Boston Scientific
Aug 03, 2026
Director
Informative Buy
227.35K
$1.50M
Aetna Inc
Jun 03, 2015
―
Uninformative Buy
―
$2.81M
CVS Health
May 02, 2024
Director
Informative Buy
53.87K
$3.13M
Xylem
May 12, 2016
Director
Uninformative Buy
―
$2.29M
Becton Dickinson
Jul 11, 2012
Chairman, Director
Uninformative Sell
―
$28.85M
List of latest transactions for each holding click on a transaction to see Edward Ludwig's performance on stock
You May Also Like
Edward Ludwig insider profile FAQ
What is the percentage of profitable transactions made by Edward Ludwig?
The percentage of profitable transactions made by Edward Ludwig is 63%.
What is the average return per transaction made by Edward Ludwig?
The average return per transaction made by Edward Ludwig is 9.50%.
What stocks does Edward Ludwig hold?
Edward Ludwig holds: BSX, AET, CVS, XYL, BDX stocks.
What was Edward Ludwig’s latest transaction?
Edward Ludwig latest transaction was an Informative Buy of $227.35K.
What was Edward Ludwig's most profitable transaction?
Edward Ludwig’s most profitable transaction was an Informative Sell of BSX stock on July 28, 2025. The return on the trade was 46.00%.
What is Edward Ludwig's role in Boston Scientific?
Edward Ludwig's role in Boston Scientific is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.